RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
- Capital expenditures, 2025
- $410K
- YoY, 2025
- −79.7%
- 5-year CAGR
- −26.6%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $410K | −79.7% |
| 2024 | $2.0M | −51.1% |
| 2023 | $4.1M | −54.5% |
| 2022 | $9.1M | +161.1% |
| 2021 | $3.5M | +79.8% |
| 2020 | $1.9M | −75.9% |
| 2019 | $8.0M | — |